Rapid Microbiology Testing Market By Technology Type (Nucleic acid based amplification tests, Immunology based Methods, Flow Cytometry based Methods, Mass Spectrometry based Methods, Biochemical Tests and Growth-based detection technologies), By Application (Process water testing, Raw Material testing, In-Process testing, Bioburden assessment, Microbial limit testing, environment monitoring and sterility testing) - Global Industry Analysis & Forecast to 2027

Published On : September 2018 Pages : 152 Category: Pharma & Healthcare Report Code : HC091305

Industry Outlook and Trend Analysis

The Rapid Microbiology Testing Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Rapid microbiology tests, otherwise called alternative microbiological methods, are technologies that enable users to get microbiology test results quicker in comparison with the customary culture-plate techniques. Rapid microbiology testing gives the quantitative, qualitative, and recognizable outcomes.  In the following couple of years the interest for rapid microbiology tests in pharmaceutical industry is anticipated to increment essentially in the developing economies, for example, China and India. The type of technology considered for studying the general rapid microbiology tests in pharmaceutical industry are into immunology based techniques, nucleic acid amplification tests, flow cytometry based methods, mass spectrometry based strategies, and development based recognition advancements and biochemical tests.

Technology Outlook and Trend Analysis

On the basis of technology the nucleic acid amplification tests based methods captured the largest share in the rapid microbiology market owing to its wide application in the pharmaceutical sector. Moreover, low cost and high speed is anticipated to further boost the market development of immunology based methods.

End User Outlook and Trend Analysis

Based on end user, the sterility testing application captured the biggest share in the global rapid microbiology tests in pharmaceutical market owing its wide application in the final drug product and other applications. Process water testing is foreseen to encounter the highest development in the global rapid microbiology tests in the pharmaceutical industry market.

Regional Outlook and Trend Analysis

Geographically, North America represented the largest market in the rapid microbiology tests market owing to the presence of major life science organizations in the region. Moreover, improved government initiatives in the region are foreseen to regulate the rapid microbiological testing in the industrial setting, particularly in the pharmaceutical sector has further assisted the development of rapid microbiology tests market in the region.

Competitive Insights

The major players in the market are Danaher Corporation, Charles River Laboratories, Merck Group, OraSure Technologies, Sysmex Corporation, Bruker, Alere Inc, Siemens Healthineers, Vivione Biosciences LLC, Becton Dickinson, Thermo Fisher Scientific, Neogen, Quidel Corporation, Don Whitley Scientific Limited, Bio-Rad Laboratories, Roche Holding AG, Abbott Laboratories and Gen-Probe. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

The Rapid Microbiology Testing Market is segmented as follows-

By Technology:

  • Mass Spectrometry based Methods
  • Growth-based detection technologies
  • Immunology based Methods
  • Nucleic acid based amplification tests
  • Flow Cytometry based Methods
  • Biochemical Tests

By End User:

  • In-process testing
  • Bioburden assessment
  • Environmental monitoring
  • Raw material testing
  • Microbial limit testing
  • Process water testing
  • Sterility testing

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • South Africa
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Rapid Microbiology Testing Market, By Technology Type, Estimates and Forecast, 2017-2027 ($Million)

·         Mass Spectrometry based Methods

·         Growth-based detection technologies

·         Immunology based Methods

·         Nucleic acid based amplification tests

·         Flow Cytometry based Methods

·         Biochemical Tests

·         Rapid Microbiology Testing Market, By End User, Estimates and Forecast, 2017-2027 ($Million)

·         In-process testing

·         Bioburden assessment

·         Environmental monitoring

·         Raw material testing

·         Microbial limit testing

·         Process water testing

·         Sterility testing

·         Rapid Microbiology Testing Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

·         North America

§  North America Rapid Microbiology Testing Market, By Country

o    U.S. Rapid Microbiology Testing Market

o    Canada Rapid Microbiology Testing Market

o    Mexico Rapid Microbiology Testing Market

·         Europe

§  Europe Rapid Microbiology Testing Market, By Country

o    Germany Rapid Microbiology Testing Market

o    UK Rapid Microbiology Testing Market

o    France Rapid Microbiology Testing Market

o    Russia Rapid Microbiology Testing Market

o    Italy Rapid Microbiology Testing Market

o    Rest of Europe Rapid Microbiology Testing Market

·         Asia-Pacific

§  Asia-Pacific Rapid Microbiology Testing Market, By Country

o    China Rapid Microbiology Testing Market

o    Japan Rapid Microbiology Testing Market

o    South Korea Rapid Microbiology Testing Market

o    India Rapid Microbiology Testing Market

o    Southeast Asia Rapid Microbiology Testing Market

o    Rest of Asia-Pacific Rapid Microbiology Testing Market

·         South America

§  South America Rapid Microbiology Testing Market

o    Brazil Rapid Microbiology Testing Market

o    Argentina Rapid Microbiology Testing Market

o    Columbia Rapid Microbiology Testing Market

o    Rest of South America Rapid Microbiology Testing Market

·         Middle East and Africa

§  Middle East and Africa Rapid Microbiology Testing Market

o    Saudi Arabia Rapid Microbiology Testing Market

o    UAE Rapid Microbiology Testing Market

o    Egypt Rapid Microbiology Testing Market

o    Nigeria Rapid Microbiology Testing Market

o    South Africa Rapid Microbiology Testing Market

o    Rest of MEA Rapid Microbiology Testing Market

Table of Contents

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Rapid Microbiology Testing Market, By Technology

5.1.     Introduction

5.2.     Global Rapid Microbiology Testing  Revenue and Market Share by Technology  (2017-2027)

5.2.1.  Global Rapid Microbiology Testing  Revenue and Revenue Share by Technology  (2017-2027)

5.3.     Mass Spectrometry based Methods

5.3.1.  Global Mass Spectrometry based Methods Revenue and Growth Rate (2017-2027)

5.4.     Growth-based detection technologies

5.4.1.  Global Growth-based detection technologies Revenue and Growth Rate (2017-2027)

5.5.     Immunology based Methods

5.5.1.  Global Immunology based Methods Revenue and Growth Rate (2017-2027)

5.6.     Nucleic acid based amplification tests

5.6.1.  Global Nucleic acid based amplification tests Revenue and Growth Rate (2017-2027)

5.7.     Flow Cytometry based Methods

5.7.1.  Global Flow Cytometry based Methods Revenue and Growth Rate (2017-2027)

5.8.     Biochemical Tests

5.8.1.  Global Biochemical Tests Revenue and Growth Rate (2017-2027)

6.       Rapid Microbiology Testing Market, By End User

6.1.     Introduction

6.2.     Global Rapid Microbiology Testing  Revenue and Market Share by End User  (2017-2027)

6.2.1.  Global Rapid Microbiology Testing  Revenue and Revenue Share by End User  (2017-2027)

6.3.     In-process testing

6.3.1.  Global In-process testing Revenue and Growth Rate (2017-2027)

6.4.     Bioburden assessment

6.4.1.  Global Bioburden assessment Revenue and Growth Rate (2017-2027)

6.5.     Environmental monitoring

6.5.1.  Global Environmental monitoring Revenue and Growth Rate (2017-2027)

6.6.     Raw material testing

6.6.1.  Global Raw material testing Revenue and Growth Rate (2017-2027)

6.7.     Microbial limit testing

6.7.1.  Global Microbial limit testing Revenue and Growth Rate (2017-2027)

6.8.     Process water testing

6.8.1.  Global Process water testing Revenue and Growth Rate (2017-2027)

6.9.     Sterility testing

6.9.1.  Global Sterility testing Revenue and Growth Rate (2017-2027)

7.       Rapid Microbiology Testing Market, By Region

7.1.     Introduction

7.2.     Global Rapid Microbiology Testing  Revenue and Market Share by Regions

7.2.1.  Global Rapid Microbiology Testing  Revenue by Regions (2017-2027)

7.3.     North America Rapid Microbiology Testing  by Countries

7.3.1.  North America Rapid Microbiology Testing  Revenue and Growth Rate (2017-2027)

7.3.2.  North America Rapid Microbiology Testing  Revenue (Million USD) by Countries (2017-2027)

7.3.3.  United States

7.3.3.1. United States Rapid Microbiology Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.4.  Canada

7.3.4.1. Canada Rapid Microbiology Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.5.  Mexico

7.3.5.1. Mexico Rapid Microbiology Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.     Europe Rapid Microbiology Testing  by Countries

7.4.1.  Europe Rapid Microbiology Testing  Revenue and Growth Rate (2017-2027)

7.4.2.  Europe Rapid Microbiology Testing  Revenue (Million USD) by Countries (2017-2027)

7.4.3.  Germany

7.4.3.1. Germany Rapid Microbiology Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.4.  France

7.4.4.1. France Rapid Microbiology Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.5.  UK

7.4.5.1. UK Rapid Microbiology Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.6.  Russia

7.4.6.1. Russia Rapid Microbiology Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.7.  Italy

7.4.7.1. Italy Rapid Microbiology Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.8.  Rest of Europe

7.4.8.1. Rest of Europe Rapid Microbiology Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.     Asia-Pacific Rapid Microbiology Testing  by Countries

7.5.1.  Asia-Pacific Rapid Microbiology Testing  Revenue and Growth Rate (2017-2027)

7.5.2.  Asia-Pacific Rapid Microbiology Testing  Revenue (Million USD) by Countries (2017-2027)

7.5.3.  China

7.5.3.1. China Rapid Microbiology Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.4.  Japan

7.5.4.1. Japan Rapid Microbiology Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.5.  Korea

7.5.5.1. Korea Rapid Microbiology Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6.  India

7.5.6.1. India Rapid Microbiology Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.7.  Southeast Asia

7.5.7.1. Southeast Asia Rapid Microbiology Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.8.  Rest of Asia-Pacific

7.5.8.1. Rest of Asia-Pacific Rapid Microbiology Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.     South America Rapid Microbiology Testing  by Countries

7.6.1.  South America Rapid Microbiology Testing  Revenue and Growth Rate (2017-2027)

7.6.2.  South America Rapid Microbiology Testing  Revenue (Million USD) by Countries (2017-2027)

7.6.3.  Brazil

7.6.3.1. Brazil Rapid Microbiology Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.4.  Argentina

7.6.4.1. Argentina Rapid Microbiology Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.5.  Columbia

7.6.5.1. Columbia Rapid Microbiology Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.6.  Rest of South America

7.6.6.1. Rest of South America Rapid Microbiology Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.     Middle East and Africa Rapid Microbiology Testing  by Countries

7.7.1.  Middle East and Africa Rapid Microbiology Testing  Revenue and Growth Rate (2017-2027)

7.7.2.  Middle East and Africa Rapid Microbiology Testing  Revenue (Million USD) by Countries (2017-2027)

7.7.3.  Saudi Arabia

7.7.3.1. Saudi Arabia Rapid Microbiology Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.4.  United Arab Emirates

7.7.4.1. United Arab Emirates Rapid Microbiology Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.5.  Egypt

7.7.5.1. Egypt Rapid Microbiology Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.6.  Nigeria

7.7.6.1. Nigeria Rapid Microbiology Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.7.  South Africa

7.7.7.1. South Africa Rapid Microbiology Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.8.  Turkey

7.7.8.1. Turkey Rapid Microbiology Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.9.  Rest of Middle East and Africa

7.7.9.1. Rest of Middle East and Africa Rapid Microbiology Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

8.       Company Profiles

8.1.     Danaher Corporation

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.   Revenue and Market Share

8.2.     Charles River Laboratories

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.   Revenue and Market Share

8.3.     Merck Group

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.   Revenue and Market Share

8.4.     OraSure Technologies

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.   Revenue and Market Share

8.5.     Sysmex Corporation

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.   Revenue and Market Share

8.6.     Bruker

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.   Revenue and Market Share

8.7.     Alere Inc

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.   Revenue and Market Share

8.8.     Siemens Healthineers

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.   Revenue and Market Share

8.9.     Vivione Biosciences LLC

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.   Revenue and Market Share

8.10. Becton Dickinson

8.10.1.      Business Overview

8.10.2.       Service Portfolio

8.10.3.      Strategic Developments

8.10.4.       Revenue and Market Share

8.11. Thermo Fisher Scientific

8.11.1.      Business Overview

8.11.2.       Service Portfolio

8.11.3.      Strategic Developments

8.11.4.       Revenue and Market Share

8.12. Neogen

8.12.1.      Business Overview

8.12.2.       Service Portfolio

8.12.3.      Strategic Developments

8.12.4.       Revenue and Market Share

8.13. Quidel Corporation

8.13.1.      Business Overview

8.13.2.       Service Portfolio

8.13.3.      Strategic Developments

8.13.4.       Revenue and Market Share

8.14. Don Whitley Scientific Limited

8.14.1.      Business Overview

8.14.2.       Service Portfolio

8.14.3.      Strategic Developments

8.14.4.       Revenue and Market Share

8.15. Bio-Rad Laboratories

8.15.1.      Business Overview

8.15.2.       Service Portfolio

8.15.3.      Strategic Developments

8.15.4.       Revenue and Market Share

8.16. Roche Holding AG

8.16.1.      Business Overview

8.16.2.       Service Portfolio

8.16.3.      Strategic Developments

8.16.4.       Revenue and Market Share

8.17. Abbott Laboratories

8.17.1.      Business Overview

8.17.2.       Service Portfolio

8.17.3.      Strategic Developments

8.17.4.       Revenue and Market Share

8.18. Gen-Probe

8.18.1.      Business Overview

8.18.2.       Service Portfolio

8.18.3.      Strategic Developments

8.18.4.       Revenue and Market Share

9.       Global Rapid Microbiology Testing Market Competition, by Manufacturer

9.1.     Global Rapid Microbiology Testing  Revenue and Market Share by Manufacturer (2017-2017)

9.2.     Global Rapid Microbiology Testing  Price By Region (2017-2017)

9.3.     Top 5 Rapid Microbiology Testing Manufacturer Market Share

9.4.     Market Competition Trend

10.    Rapid Microbiology Testing Market Forecast (2017-2027)

10.1. Global Rapid Microbiology Testing  Revenue (Millions USD) and Growth Rate (2017-2027)

10.2. Rapid Microbiology Testing Market Forecast by Regions (2017-2027)

10.2.1.      North America Rapid Microbiology Testing Market Forecast (2017-2027)

10.2.1.1. United States Rapid Microbiology Testing Market Forecast (2017-2027)

10.2.1.2. Canada Rapid Microbiology Testing Market Forecast (2017-2027)

10.2.1.3. Mexico Rapid Microbiology Testing Market Forecast (2017-2027)

10.2.2.      Europe Rapid Microbiology Testing Market Forecast (2017-2027)

10.2.2.1. Germany Rapid Microbiology Testing Market Forecast (2017-2027)

10.2.2.2. France Rapid Microbiology Testing Market Forecast (2017-2027)

10.2.2.3. UK Rapid Microbiology Testing Market Forecast (2017-2027)

10.2.2.4. Russia Rapid Microbiology Testing Market Forecast (2017-2027)

10.2.2.5. Italy Rapid Microbiology Testing Market Forecast (2017-2027)

10.2.2.6. Rest of Europe Rapid Microbiology Testing Market Forecast (2017-2027)

10.2.3.      Asia-Pacific Rapid Microbiology Testing Market Forecast (2017-2027)

10.2.3.1. China Rapid Microbiology Testing Market Forecast (2017-2027)

10.2.3.2. Japan Rapid Microbiology Testing Market Forecast (2017-2027)

10.2.3.3. Korea Rapid Microbiology Testing Market Forecast (2017-2027)

10.2.3.4. India Rapid Microbiology Testing Market Forecast (2017-2027)

10.2.3.5. Southeast Asia Rapid Microbiology Testing Market Forecast (2017-2027)

10.2.3.6. Rest of Asia-Pacific Rapid Microbiology Testing Market Forecast (2017-2027)

10.2.4.      South America Rapid Microbiology Testing Market Forecast (2017-2027)

10.2.4.1. Brazil Rapid Microbiology Testing Market Forecast (2017-2027)

10.2.4.2. Argentina Rapid Microbiology Testing Market Forecast (2017-2027)

10.2.4.3. Columbia Rapid Microbiology Testing Market Forecast (2017-2027)

10.2.4.4. Rest of South America Rapid Microbiology Testing Market Forecast (2017-2027)

10.2.5.      Middle East and Africa Rapid Microbiology Testing Market Forecast (2017-2027)

10.2.5.1. Saudi Arabia Rapid Microbiology Testing Market Forecast (2017-2027)

10.2.5.2. United Arab Emirates Rapid Microbiology Testing Market Forecast (2017-2027)

10.2.5.3. Egypt Rapid Microbiology Testing Market Forecast (2017-2027)

10.2.5.4. Nigeria Rapid Microbiology Testing Market Forecast (2017-2027)

10.2.5.5. South Africa Rapid Microbiology Testing Market Forecast (2017-2027)

10.2.5.6. Turkey Rapid Microbiology Testing Market Forecast (2017-2027)

10.2.5.7. Rest of Middle East and Africa Rapid Microbiology Testing Market Forecast (2017-2027)

10.3. Rapid Microbiology Testing Market Forecast by Technology  (2017-2027)

10.3.1.      Rapid Microbiology Testing  Forecast by Technology  (2017-2027)

10.3.2.      Rapid Microbiology Testing Market Share Forecast by Technology  (2017-2027)

10.4. Rapid Microbiology Testing Market Forecast by End User  (2017-2027)

10.4.1.      Rapid Microbiology Testing  Forecast by End User  (2017-2027)

10.4.2.      Rapid Microbiology Testing Market Share Forecast by End User  (2017-2027)


List of Tables

11. List of Tables and Figures

Figure United States Rapid Microbiology Testing Revenue (Million USD) and Growth Rate (2017-2025)

Figure Canada Rapid Microbiology Testing Revenue (Million USD) and Growth Rate (2017-2025)

Figure Mexico Rapid Microbiology Testing Revenue (Million USD) and Growth Rate (2017-2025)

Figure Germany Rapid Microbiology Testing Revenue (Million USD) and Growth Rate (2017-2025)

Figure France Rapid Microbiology Testing Revenue (Million USD) and Growth Rate (2017-2025)

Figure UK Rapid Microbiology Testing Revenue (Million USD) and Growth Rate (2017-2025)

Figure Russia Rapid Microbiology Testing Revenue (Million USD) and Growth Rate (2017-2025)

Figure Italy Rapid Microbiology Testing Revenue (Million USD) and Growth Rate (2017-2025)

Figure Rest of Europe Rapid Microbiology Testing Revenue (Million USD) and Growth Rate (2017-2025)

Figure China Rapid Microbiology Testing Revenue (Million USD) and Growth Rate (2017-2025)

Figure Japan Rapid Microbiology Testing Revenue (Million USD) and Growth Rate (2017-2025)

Figure Korea Rapid Microbiology Testing Revenue (Million USD) and Growth Rate (2017-2025)

Figure India Rapid Microbiology Testing Revenue (Million USD) and Growth Rate (2017-2025)

Figure Southeast Asia Rapid Microbiology Testing Revenue (Million USD) and Growth Rate (2017-2025)

Figure Rest of Asia-Pacific Rapid Microbiology Testing Revenue (Million USD) and Growth Rate (2017-2025)

Figure Brazil Rapid Microbiology Testing Revenue (Million USD) and Growth Rate (2017-2025)

Figure Argentina Rapid Microbiology Testing Revenue (Million USD) and Growth Rate (2017-2025)

Figure Columbia Rapid Microbiology Testing Revenue (Million USD) and Growth Rate (2017-2025)

Figure Rest of South America Rapid Microbiology Testing Revenue (Million USD) and Growth Rate (2017-2025)

Figure Saudi Arabia Rapid Microbiology Testing Revenue (Million USD) and Growth Rate (2017-2025)

Figure United Arab Emirates Rapid Microbiology Testing Revenue (Million USD) and Growth Rate (2017-2025)

Figure Egypt Rapid Microbiology Testing Revenue (Million USD) and Growth Rate (2017-2025)

Figure Nigeria Rapid Microbiology Testing Revenue (Million USD) and Growth Rate (2017-2025)

Figure South Africa Rapid Microbiology Testing Revenue (Million USD) and Growth Rate (2017-2025)

Figure Turkey Rapid Microbiology Testing Revenue (Million USD) and Growth Rate (2017-2025)

Figure Rest of Middle East and Africa Rapid Microbiology Testing Revenue (Million USD) and Growth Rate (2017-2025)

Table Global Rapid Microbiology Testing Revenue and Revenue Share by Technology (2017-2018)

Figure Global Mass Spectrometry based Methods Revenue and Growth Rate (2017-2018)

Figure Global Growth-based detection technologies Revenue and Growth Rate (2017-2018)

Figure Global Immunology based Methods Revenue and Growth Rate (2017-2018)

Figure Global Nucleic acid based amplification tests Revenue and Growth Rate (2017-2018)

Figure Global Flow Cytometry based Methods Revenue and Growth Rate (2017-2018)

Figure Global Biochemical Tests Revenue and Growth Rate (2017-2018)

Table Global Rapid Microbiology Testing Revenue and Revenue Share by End User (2017-2018)

Figure Global In-process testing Revenue and Growth Rate (2017-2018)

Figure Global Bioburden assessment Revenue and Growth Rate (2017-2018)

Figure Global Environmental monitoring Revenue and Growth Rate (2017-2018)

Figure Global Raw material testing Revenue and Growth Rate (2017-2018)

Figure Global Microbial limit testing Revenue and Growth Rate (2017-2018)

Figure Global Process water testing Revenue and Growth Rate (2017-2018)

Figure Global Sterility testing Revenue and Growth Rate (2017-2018)

Table Global Rapid Microbiology Testing Revenue by Regions (2017-2018)

Figure North America Rapid Microbiology Testing Growth Rate (2017-2018)

Figure North America Rapid Microbiology Testing Revenue and Growth Rate (2017-2018)

Figure North America Rapid Microbiology Testing by Countries (2017-2018)

Figure North America Rapid Microbiology Testing Revenue (Million USD) by Countries (2017-2018)

Figure United States Rapid Microbiology Testing Growth Rate (2017-2018)

Figure United States Rapid Microbiology Testing Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Canada Rapid Microbiology Testing Growth Rate (2017-2018)

Figure Canada Rapid Microbiology Testing Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Mexico Rapid Microbiology Testing Growth Rate (2017-2018)

Figure Mexico Rapid Microbiology Testing Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Europe Rapid Microbiology Testing Growth Rate (2017-2018)

Figure Europe Rapid Microbiology Testing Revenue and Growth Rate (2017-2018)

Figure Europe Rapid Microbiology Testing by Countries (2017-2018)

Figure Europe Rapid Microbiology Testing Revenue (Million USD) by Countries (2017-2018)

Figure Germany Rapid Microbiology Testing Growth Rate (2017-2018)

Figure Germany Rapid Microbiology Testing Revenue (Millions USD) and Growth Rate (2017-2018)

Figure France Rapid Microbiology Testing Growth Rate (2017-2018)

Figure France Rapid Microbiology Testing Revenue (Millions USD) and Growth Rate (2017-2018)

Figure UK Rapid Microbiology Testing Growth Rate (2017-2018)

Figure UK Rapid Microbiology Testing Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Russia Rapid Microbiology Testing Growth Rate (2017-2018)

Figure Russia Rapid Microbiology Testing Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Italy Rapid Microbiology Testing Growth Rate (2017-2018)

Figure Italy Rapid Microbiology Testing Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Rest of Europe Rapid Microbiology Testing Growth Rate (2017-2018)

Figure Rest of Europe Rapid Microbiology Testing Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Asia-Pacific Rapid Microbiology Testing Growth Rate (2017-2018)

Figure Asia-Pacific Rapid Microbiology Testing Revenue and Growth Rate (2017-2018)

Figure Asia-Pacific Rapid Microbiology Testing by Countries (2017-2018)

Figure Asia-Pacific Rapid Microbiology Testing Revenue (Million USD) by Countries (2017-2018)

Figure China Rapid Microbiology Testing Growth Rate (2017-2018)

Figure China Rapid Microbiology Testing Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Japan Rapid Microbiology Testing Growth Rate (2017-2018)

Figure Japan Rapid Microbiology Testing Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Korea Rapid Microbiology Testing Growth Rate (2017-2018)

Figure Korea Rapid Microbiology Testing Revenue (Millions USD) and Growth Rate (2017-2018)

Figure India Rapid Microbiology Testing Growth Rate (2017-2018)

Figure India Rapid Microbiology Testing Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Southeast Asia Rapid Microbiology Testing Growth Rate (2017-2018)

Figure Southeast Asia Rapid Microbiology Testing Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Rest of Asia-Pacific Rapid Microbiology Testing Growth Rate (2017-2018)

Figure Rest of Asia-Pacific Rapid Microbiology Testing Revenue (Millions USD) and Growth Rate (2017-2018)

Figure South America Rapid Microbiology Testing Growth Rate (2017-2018)

Figure South America Rapid Microbiology Testing Revenue and Growth Rate (2017-2018)

Figure South America Rapid Microbiology Testing by Countries (2017-2018)

Figure South America Rapid Microbiology Testing Revenue (Million USD) by Countries (2017-2018)

Figure Brazil Rapid Microbiology Testing Growth Rate (2017-2018)

Figure Brazil Rapid Microbiology Testing Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Argentina Rapid Microbiology Testing Growth Rate (2017-2018)

Figure Argentina Rapid Microbiology Testing Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Columbia Rapid Microbiology Testing Growth Rate (2017-2018)

Figure Columbia Rapid Microbiology Testing Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Rest of South America Rapid Microbiology Testing Growth Rate (2017-2018)

Figure Rest of South America Rapid Microbiology Testing Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Middle East and Africa Rapid Microbiology Testing Growth Rate (2017-2018)

Figure Middle East and Africa Rapid Microbiology Testing Revenue and Growth Rate (2017-2018)

Figure Middle East and Africa Rapid Microbiology Testing by Countries (2017-2018)

Figure Middle East and Africa Rapid Microbiology Testing Revenue (Million USD) by Countries (2017-2018)

Figure Saudi Arabia Rapid Microbiology Testing Growth Rate (2017-2018)

Figure Saudi Arabia Rapid Microbiology Testing Revenue (Millions USD) and Growth Rate (2017-2018)

Figure United Arab Emirates Rapid Microbiology Testing Growth Rate (2017-2018)

Figure United Arab Emirates Rapid Microbiology Testing Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Egypt Rapid Microbiology Testing Growth Rate (2017-2018)

Figure Egypt Rapid Microbiology Testing Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Nigeria Rapid Microbiology Testing Growth Rate (2017-2018)

Figure Nigeria Rapid Microbiology Testing Revenue (Millions USD) and Growth Rate (2017-2018)

Figure South Africa Rapid Microbiology Testing Growth Rate (2017-2018)

Figure South Africa Rapid Microbiology Testing Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Turkey Rapid Microbiology Testing Growth Rate (2017-2018)

Figure Turkey Rapid Microbiology Testing Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Rest of Middle East and Africa Rapid Microbiology Testing Growth Rate (2017-2018)

Figure Rest of Middle East and Africa Rapid Microbiology Testing Revenue (Millions USD) and Growth Rate (2017-2018)

Table Danaher Corporation Rapid Microbiology Testing Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Charles River Laboratories Rapid Microbiology Testing Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Merck Group Rapid Microbiology Testing Price, Revenue, Gross Margin and Market Share (2017-2017)

Table OraSure Technologies Rapid Microbiology Testing Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Sysmex Corporation Rapid Microbiology Testing Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Bruker Rapid Microbiology Testing Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Alere Inc Rapid Microbiology Testing Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Siemens Healthineers Rapid Microbiology Testing Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Vivione Biosciences LLC Rapid Microbiology Testing Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Becton Dickinson Rapid Microbiology Testing Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Thermo Fisher Scientific Rapid Microbiology Testing Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Neogen Rapid Microbiology Testing Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Quidel Corporation Rapid Microbiology Testing Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Don Whitley Scientific Limited Rapid Microbiology Testing Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Bio-Rad Laboratories Rapid Microbiology Testing Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Roche Holding AG Rapid Microbiology Testing Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Abbott Laboratories Rapid Microbiology Testing Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Gen-Probe Rapid Microbiology Testing Price, Revenue, Gross Margin and Market Share (2017-2017)

Figure Global Rapid Microbiology Testing Market Share by Manufacturer

Figure Global Rapid Microbiology Testing Revenue and Market Share by Manufacturer

Table Global Rapid Microbiology Testing Price by Region (2017-2017)

Figure Top 5 Rapid Microbiology Testing Manufacturer (Revenue) Market Share

Figure Market Competition Trend

Figure Global Rapid Microbiology Testing Revenue (Millions USD) and Growth Rate (2018-2025)

Table Rapid Microbiology Testing Market Forecast by Regions (2018-2025)

Figure North America Rapid Microbiology Testing Market Forecast (2018-2025)

Figure United States Rapid Microbiology Testing Market Forecast (2018-2025)

Figure Canada Rapid Microbiology Testing Market Forecast (2018-2025)

Figure Mexico Rapid Microbiology Testing Market Forecast (2018-2025)

Figure Europe Rapid Microbiology Testing Market Forecast (2018-2025)

Figure Germany Rapid Microbiology Testing Market Forecast (2018-2025)

Figure France Rapid Microbiology Testing Market Forecast (2018-2025)

Figure UK Rapid Microbiology Testing Market Forecast (2018-2025)

Figure Russia Rapid Microbiology Testing Market Forecast (2018-2025)

Figure Italy Rapid Microbiology Testing Market Forecast (2018-2025)

Figure Rest of Europe Rapid Microbiology Testing Market Forecast (2018-2025)

Figure Asia-Pacific Rapid Microbiology Testing Market Forecast (2018-2025)

Figure China Rapid Microbiology Testing Market Forecast (2018-2025)

Figure Japan Rapid Microbiology Testing Market Forecast (2018-2025)

Figure Korea Rapid Microbiology Testing Market Forecast (2018-2025)

Figure India Rapid Microbiology Testing Market Forecast (2018-2025)

Figure Southeast Asia Rapid Microbiology Testing Market Forecast (2018-2025)

Figure Rest of Asia-Pacific Rapid Microbiology Testing Market Forecast (2018-2025)

Figure South America Rapid Microbiology Testing Market Forecast (2018-2025)

Figure Brazil Rapid Microbiology Testing Market Forecast (2018-2025)

Figure Argentina Rapid Microbiology Testing Market Forecast (2018-2025)

Figure Columbia Rapid Microbiology Testing Market Forecast (2018-2025)

Figure Rest of South America Rapid Microbiology Testing Market Forecast (2018-2025)

Figure Middle East and Africa Rapid Microbiology Testing Market Forecast (2018-2025)

Figure Saudi Arabia Rapid Microbiology Testing Market Forecast (2018-2025)

Figure United Arab Emirates Rapid Microbiology Testing Market Forecast (2018-2025)

Figure Egypt Rapid Microbiology Testing Market Forecast (2018-2025)

Figure Nigeria Rapid Microbiology Testing Market Forecast (2018-2025)

Figure South Africa Rapid Microbiology Testing Market Forecast (2018-2025)

Figure Turkey Rapid Microbiology Testing Market Forecast (2018-2025)

Figure Rest of Middle East and Africa Rapid Microbiology Testing Market Forecast (2018-2025)

Figure Global Rapid Microbiology Testing Forecast by Technology (2018-2025)

Figure Global Rapid Microbiology Testing Market Share Forecast by Technology (2018-2025)

Figure Global Rapid Microbiology Testing Forecast by Technology (2018-2025)

Figure Global Rapid Microbiology Testing Forecast by End User (2018-2025)

Figure Global Rapid Microbiology Testing Market Share Forecast by End User (2018-2025)

Figure Global Rapid Microbiology Testing Forecast by End User (2018-2025)

Please Note: Data related to the Companies are subject to Availability


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*